GERON CORP (GERN) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $642.00K; Additional Paid in Capital, Common StockUSD $2.09B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-339.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $641.00K; Additional Paid in Capital, Common StockUSD $2.09B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-191.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $640.00K; Additional Paid in Capital, Common StockUSD $2.08B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $269.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $638.00K; Additional Paid in Capital, Common StockUSD $2.07B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $408.00K.
GERON CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $642.00K | $2.09B | $-339.00K | $-1.88B | $218.61M | (m) | 3 month · $4.93M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $641.00K | $2.09B | $-191.00K | $-1.86B | $229.11M | 3 month · $13.00K | 3 month · $4.90M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $640.00K | $2.08B | $269.00K | $-1.86B | $225.87M | (m) | (m) | 12 month · $26.66M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $638.00K | $2.07B | $408.00K | $-1.83B | $248.71M | (m) | (m) | 3 month · $6.74M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $638.00K | $2.07B | $117.00K | $-1.81B | $259.53M | (m) | 3 month · $6.74M | 3 month · $6.74M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $637.00K | $2.06B | $304.00K | $-1.79B | $268.24M | 3 month · $15.00K | 3 month · $7.41M | 3 month · $7.41M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $606.00K | $2.05B | $261.00K | $-1.77B | $280.32M | (m) | (m) | 12 month · $31.93M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $603.00K | $2.04B | $1.02M | $-1.75B | $292.28M | (m) | (m) | 3 month · $6.89M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $601.00K | $2.03B | $-537.00K | $-1.72B | $306.69M | (m) | (m) | 3 month · $12.62M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $591.00K | $2.00B | $-273.00K | $-1.65B | $344.87M | (m) | (m) | 3 month · $4.88M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $545.00K | $1.84B | $185.00K | $-1.60B | $247.95M | (m) | (m) | 12 month · $18.53M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $542.00K | $1.84B | $-950.00K | $-1.55B | $290.61M | (m) | (m) | 3 month · $7.20M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $522.00K | $1.80B | $-945.00K | $-1.50B | $298.43M | (m) | (m) | 3 month · $3.94M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $509.00K | $1.78B | $-160.00K | $-1.45B | $326.06M | (m) | (m) | 3 month · $2.96M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $390.00K | $1.49B | $-219.00K | $-1.41B | $80.00M | (m) | (m) | 12 month · $8.00M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $382.00K | $1.48B | $-620.00K | $-1.37B | $108.17M | (m) | (m) | 3 month · $2.06M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $378.00K | $1.47B | $-782.00K | $-1.33B | $142.05M | (m) | (m) | 3 month · $2.06M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $324.00K | $1.40B | $-711.00K | $-1.30B | $97.49M | (m) | (m) | 3 month · $1.69M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $324.00K | $1.40B | $-173.00K | $-1.27B | $126.42M | (m) | (m) | 12 month · $8.08M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $321.00K | $1.39B | $16.00K | $-1.24B | $151.55M | (m) | (m) | 3 month · $2.01M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $321.00K | $1.39B | $3.00K | $-1.21B | $176.21M | (m) | (m) | 3 month · $1.97M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $318.00K | $1.38B | $35.00K | $-1.18B | $201.16M | (m) | (m) | 3 month · $1.79M | (m) | (m) | 3 month · $374.00K | (m) |
| 2020-12-31 | (m) | $310.00K | $1.37B | $78.00K | $-1.16B | $210.95M | (m) | (m) | 12 month · $6.89M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $310.00K | $1.36B | $170.00K | $-1.13B | $232.83M | (m) | (m) | 3 month · $1.77M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $310.00K | $1.36B | $189.00K | $-1.11B | $250.68M | (m) | (m) | 3 month · $1.71M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $200.00K | $1.22B | $-124.00K | $-1.10B | $120.81M | (m) | (m) | 3 month · $1.57M | (m) | (m) | 3 month · $76.00K | (m) |
| 2019-12-31 | (m) | $200.00K | $1.21B | $132.00K | $-1.08B | $135.16M | (m) | (m) | 12 month · $6.08M | (m) | (m) | 12 month · $481.00K | (m) |
| 2019-09-30 | (m) | $193.00K | $1.20B | $239.00K | $-1.05B | $152.39M | (m) | (m) | 3 month · $1.57M | (m) | (m) | 3 month · $207.00K | (m) |
| 2019-06-30 | (m) | $187.00K | $1.19B | $281.00K | $-1.04B | $157.04M | (m) | (m) | 3 month · $1.43M | (m) | (m) | 3 month · $73.00K | (m) |
| 2019-03-31 | (m) | $186.00K | $1.19B | $99.00K | $-1.02B | $169.41M | (m) | (m) | 3 month · $1.43M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $186.00K | $1.19B | $-183.00K | $-1.01B | $177.73M | (m) | (m) | 12 month · $6.37M | (m) | (m) | 12 month · $2.28M | (m) |
| 2018-09-30 | (m) | $186.00K | $1.19B | $-112.00K | $-1.00B | $183.47M | (m) | (m) | 3 month · $1.61M | (m) | (m) | 3 month · $138.00K | (m) |
| 2018-06-30 | (m) | $183.00K | $1.18B | $-77.00K | $-998.57M | $178.36M | (m) | (m) | 3 month · $1.54M | (m) | (m) | 3 month · $2.10M | (m) |
| 2018-03-31 | (m) | $161.00K | $1.09B | $-331.00K | $-991.63M | $101.13M | (m) | (m) | 3 month · $1.61M | (m) | (m) | 3 month · $48.00K | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $-984.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $160.00K | $1.09B | $-207.00K | $-985.84M | $103.80M | (m) | (m) | 12 month · $8.14M | (m) | (m) | 12 month · $114.00K | (m) |
| 2017-09-30 | (m) | $159.00K | $1.09B | $-52.00K | $-978.41M | $108.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $159.00K | $1.08B | $-79.00K | $-971.51M | $113.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $159.00K | $1.08B | $-71.00K | $-965.11M | $117.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $159.00K | $1.08B | $-53.00K | $-957.92M | $122.38M | (m) | (m) | 12 month · $8.24M | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $159.00K | $1.08B | $25.00K | $-949.44M | $128.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $159.00K | $1.08B | $90.00K | $-945.87M | $130.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $159.00K | $1.07B | $40.00K | $-937.23M | $136.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $159.00K | $1.07B | $-213.00K | $-928.39M | $142.13M | (m) | (m) | 12 month · $8.40M | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $158.00K | $1.07B | $-57.00K | $-919.92M | $147.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $158.00K | $1.07B | $-50.00K | $-947.10M | $118.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $158.00K | $1.06B | $-17.00K | $-937.75M | $125.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $157.00K | $1.06B | $-84.00K | $-928.43M | $130.71M | (m) | (m) | 12 month · $7.66M | (m) | $-84.00K | 12 month · $6.70M | (m) |
| 2014-09-30 | (m) | $157.00K | $1.06B | $-36.00K | $-919.49M | $137.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $157.00K | $1.05B | $-20.00K | $-909.94M | $144.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $157.00K | $1.05B | $-90.00K | $-901.20M | $150.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $131.00K | $952.40M | $-14.00K | $-892.76M | $59.76M | (m) | (m) | 12 month · $4.43M | (m) | $-14.00K | (m) | (m) |
| 2013-09-30 | (m) | $129.00K | $945.24M | $-12.00K | $-883.48M | $61.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $130.00K | $943.52M | $-13.00K | $-875.23M | $68.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $130.00K | $942.19M | $18.00K | $-866.28M | $76.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $130.00K | $939.87M | $40.00K | $-854.38M | $85.65M | (m) | (m) | 12 month · $5.31M | (m) | $40.00K | (m) | (m) |
| 2012-09-30 | (m) | $131.00K | $938.08M | $82.00K | $-838.52M | $99.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $131.00K | $936.72M | $-81.00K | $-822.57M | $114.20M | (m) | (m) | (m) | $-153.00K | $72.00K | (m) | (m) |
| 2012-03-31 | (m) | $132.00K | $935.07M | $-46.00K | $-804.24M | $130.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | $131.00K | $932.07M | $-91.00K | $-785.50M | $146.60M | (m) | (m) | 12 month · $15.25M | $-169.00K | $78.00K | 12 month · $0.00 | 12 month · $1.72M |
| 2011-09-30 | (m) | $132.00K | $928.90M | $-174.00K | $-753.65M | $175.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $131.00K | $925.10M | $-42.00K | $-734.13M | $191.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $123.00K | $881.36M | $-96.00K | $-688.65M | $192.74M | (m) | (m) | 12 month · $13.72M | (m) | (m) | 12 month · $6.30M | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $172.58M | (m) | (m) | 12 month · $10.57M | (m) | (m) | 12 month · $1.92M | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $168.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |